Structural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD), and Aortic Valve Stenosis) - Global Opportunity Analysis and Industry Forecast, 2014-2022
- ALL895726
- 230 Pages
- February 2017
- Medical Devices
Structural heart disease refers to cardiac defects that are congenital in nature and can also be acquired through wear & tear of heart valves or chambers of the heart. Rapid advancements in the medical field have replaced the open heart surgical procedures with non-surgical minimally invasive procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR).
Currently, the global structural heart devices market is growing at a steady pace owing to the rise in incidence of structural heart diseases (aortic stenosis and mitral regurgitation) and development of minimally invasive technologies. According to the Micro Interventional Devices, Inc., about 60 million people in the U.S. suffer from structural heart defects. Moreover, as per the National Heart, Lung and Blood Institute, more than 35,000 babies are born with congenital heart defects in the U.S. These estimates are expected to boost the demand for structural heart devices during the forecast period. High cost of surgeries, risks associated with these surgeries, and lack of skilled cardiologists restrict this market growth. However, emerging markets (India and China) and increase in demand for structural heart procedures are expected to provide lucrative opportunities to the key players. The structural heart devices market is projected to reach $12,076 million by 2022 from $6,006 million in 2015, growing at a CAGR of 10.5% from 2016 to 2022.
The report segments the market based on product type, indication, age group, and geography. Based on product type, the market is bifurcated into repair devices (annuloplasty rings, heart valve balloons, and occluders) and replacement valves (mechanical and tissue heart valves]. Based on indication, it is divided into atrial septal defect (ASD), patent foramen ovale (PFO), and ventricular septal defect (VSD), aortic valve stenosis, and others. In terms of age group, it is further categorized as pediatrics and adults. The pediatrics’ age group is segmented into newborns (0‐5 months), infants (6 months to 12 months), toddlers (1‐2 years), preschoolers (3‐5 years), school-aged children (6‐12 years), and adolescents (13‐18 years). The adult age group market is further segmented into young adults (19‐24 years), adulthood (25‐39 years), middle-aged (40‐59 years), older people/old age (60‐84 years), and very old (85+ years). Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the structural heart devices market, along with the current trends and future estimations to elucidate the imminent investment pockets.
- It presents a quantitative analysis from 2014 to 2022 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on products helps to understand the type of devices used to treat structural heart diseases.
- Competitive intelligence highlights the business practices followed by leading players across various regions.
- Comprehensive analysis of all geographical regions determines the prevailing opportunities in these regions.
- Key players and their strategies are analyzed to understand the competitive outlook of the overall market.
- Extensive analysis is conducted by following key product positioning and monitoring the top contenders within the market framework.
KEY MARKET SEGMENTS
By Product
- Repair Devices
- Annuloplasty Rings
- Heart Valve Balloons
- Occluders
- Replacement Valves
- Mechanical Heart Valves
- Tissue Heart Valves
By Indication
- Atrial Septal Defect (ASD)
- Ventricular Septal Defect (VSD)
- Patent Foramen Ovale (PFO)
- Aortic Valve Stenosis
- Others
By Age Group
- Pediatric
- Newborns (0‐5 months)
- Infants (6 months to 12 months)
- Toddlers (1‐2 years)
- Preschoolers (3‐5 years)
- School-aged children (6‐12 years)
- Adolescents (13‐18)
- Adults
- Young Adults (19‐24 years)
- Adulthood (25‐39 years)
- Middle-aged Persons (40‐59 years)
- Older People/Old Age (60‐84 years)
- Very Old (85+ years)
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Israel
- Saudi Arabia
- Rest of LAMEA
List of key players profiled in the report
- Medtronic plc
- St. Jude Medical, Inc.
- Braile Biomedica
- Medical Technology Est.
- Boston Scientific Corporation
- Micro Interventional Devices, Inc.
- Edwards Lifesciences Corporation
- LivaNova PLC
- JenaValve Technology, Inc.
- Cryolife, Inc.
List of other players in the value chain (profiles not included in the report)
- Corvia Medical, Inc.
- CardioKinetix, Inc.
- Biomerics, LLC
- Lepu Medical Technology (Beijing) Co., Ltd.
- XELTIS BV
- Comed B.V.
Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.1.1. Key benefits for stakeholders
1.1.2. Key market segments
1.2. RESEARCH METHODOLOGY
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models
Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.2.3. Market share analysis, 2015
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Rise in number of patients suffering from structural heart diseases
3.3.1.2. Increase in risk of cardiovascular diseases owing to growing globalization and industrialization
3.3.1.3. Technological advancements in heart repair and replacement devices
3.3.1.4. Growth in demand for minimally invasive procedures
3.3.2. Restraints
3.3.2.1. High cost and risk associated with the treatment procedures
3.3.2.2. Stringent approval process for structural heart devices
3.3.3. Opportunities
3.3.3.1. Lucrative opportunities in emerging economies
3.4. MITRACLIP MITRAL VALVE REPAIR SYSTEM
3.5. GOVERNMENT REGULATIONS
3.5.1. FDA
3.5.2. Health Canada
3.5.3. CE Mark
3.5.4. Ministry of Health, Labour and Welfare (MHLW)
3.5.5. Therapeutic Goods Administration (TGA)
3.6. REIMBURSEMENT SCENARIO
3.7. CLINICAL TRIALS
Chapter: 4 STRUCTURAL HEART DEVICES MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. STRUCTURAL HEART REPAIR DEVICES
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Occluders
4.2.4.1. Market size and forecast
4.2.5. Annuloplasty Rings
4.2.5.1. Market size and forecast
4.2.6. Heart Valve Balloons
4.2.6.1. Market size and forecast
4.3. STRUCTURAL HEART REPLACEMENT DEVICES
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Mechanical valves
4.3.5. Market size and forecast
4.3.6. Tissue valves
4.3.7. Market size and forecast
Chapter: 5 STRUCTURAL HEART DEVICES MARKET, BY AGE GROUP
5.1. OVERVIEW
5.1.1. Market Size and Forecast
5.2. PEDIATRIC
5.2.1. Newborns
5.2.2. Infants
5.2.3. Toddlers
5.2.4. Preschoolers
5.2.5. School-aged children
5.2.6. Adolescents
5.2.7. Market size and forecast
5.3. ADULTS
5.3.1. Young adults
5.3.2. Adulthood
5.3.3. Middle-aged persons
5.3.4. Older people/old age
5.3.5. Very old
5.3.6. Market size and forecast
Chapter: 6 STRUCTURAL HEART DEVICES MARKET, BY INDICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. ATRIAL SEPTAL DEFECT
6.2.1. Market size and forecast
6.3. PATENT FORAMEN OVALE
6.3.1. Market size and forecast
6.4. VENTRICULAR SEPTAL DEFECT
6.4.1. Market size and forecast
6.5. AORTIC VALVE STENOSIS
6.5.1. Market size and forecast
6.6. OTHER INDICATIONS
6.6.1. Market size and forecast
Chapter: 7 STRUCTURAL HEART DEVICES MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Australia market size and forecast
7.4.8. Malaysia market size and forecast
7.4.9. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. South Africa market size and forecast
7.5.6. South Arabia market size and forecast
7.5.7. Rest of LAMEA market size and forecast
Chapter: 8 COMPANY PROFILES
8.1. ST. JUDE MEDICAL, INC.
8.1.1. Overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments, 2012-2016
8.2. BRAILE BIOMEDICA
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating product categories
8.3. BOSTON SCIENTIFIC CORPORATION
8.3.1. Overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments, 2011-2016
8.4. CRYOLIFE, INC.
8.4.1. Overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments, 2011-2016
8.5. EDWARDS LIFESCIENCES CORPORATION
8.5.1. Overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments, 2014-2016
8.6. JENAVALVE TECHNOLOGY, INC.
8.6.1. Overview
8.6.2. Company snapshot
8.6.3. Key strategic moves and developments, 2011-2013
8.7. LIVANOVA PLC
8.7.1. Overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments, 2016
8.8. MEDICAL TECHNOLOGY EST.
8.8.1. Overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.9. MEDTRONIC PLC
8.9.1. Overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments, 2015-2016
8.10. MICRO INTERVENTIONAL DEVICES, INC.
8.10.1. Overview
8.10.2. Company snapshot
8.10.3. Operating business segments
LIST OF TABLES
TABLE 1. RECALLED PRODUCT
TABLE 2. CPT CODE FOR HEART VALVE TECHNOLOGIES OF EDWARD LIFESCIENCES
TABLE 3. CPT CODE RELATED TO TAVR OF EDWARD LIFESCIENCES
TABLE 4. GLOBAL STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 5. GLOBAL STRUCTURAL HEART REPAIR DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 6. GLOBAL STRUCTURAL HEART REPAIR DEVICES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 7. OCCLUDERS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 8. NORTH AMERICA OCCLUDERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 9. EUROPE OCCLUDERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 10. ASIA-PACIFIC OCCLUDERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 11. LAMEA OCCLUDERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 12. GLOBAL OCCLUDERS MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 13. ANNULOPLASTY RINGS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 14. NORTH AMERICA ANNULOPLASTY RINGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 15. EUROPE ANNULOPLASTY RINGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 16. ASIA-PACIFIC ANNULOPLASTY RINGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 17. LAMEA ANNULOPLASTY RINGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 18. ANNULOPLASTY RINGS MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 19. HEART VALVE BALLOONS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 20. NORTH AMERICA HEART VALVE BALLOONS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 21. EUROPE HEART VALVE BALLOONS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 22. ASIA-PACIFIC HEART VALVE BALLOONS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 23. LAMEA HEART VALVE BALLOONS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 24. GLOBAL HEART VALVE BALLOONS MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 25. GLOBAL STRUCTURAL HEART REPLACEMENT DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 26. GLOBAL STRUCTURAL HEART REPLACEMENT DEVICES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 27. MECHANICAL HEART VALVES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 28. NORTH AMERICA MECHANICAL HEART VALVES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 29. EUROPE MECHANICAL HEART VALVES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 30. ASIA-PACIFIC MECHANICAL HEART VALVES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 31. LAMEA MECHANICAL HEART VALVES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 32. GLOBAL MECHANICAL HEART VALVES MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 33. TISSUE HEART VALVES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 34. NORTH AMERICA TISSUE HEART VALVES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 35. EUROPE TISSUE HEART VALVES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 36. ASIA-PACIFIC TISSUE HEART VALVES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 37. LAMEA TISSUE HEART VALVES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 38. GLOBAL TISSUE HEART VALVES MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 39. GLOBAL STRUCTURAL HEART DEVICES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 40. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR PEDIATRICS, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 41. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR ADULTS, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 42. GLOBAL STRUCTURAL HEART DEVICES MARKET, BY INDICATION, 2014-2022
TABLE 43. NORTH AMERICA STRUCTURAL HEART DEVICES MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 44. EUROPE STRUCTURAL HEART DEVICES MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 45. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 46. LAMEA STRUCTURAL HEART DEVICES MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 47. ATRIAL SEPTAL DEFECT MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 48. PATENT FORAMEN OVALE MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 49. VENTRICULAR SEPTAL DEFECT MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 50. AORTIC VALVE STENOSIS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 51. STRUCTURAL HEART DEVICES MARKET FOR OTHER INDICATIONS, BY REGION, 2014-2022 ($MILLION)
TABLE 52. STRUCTURAL HEART DEVICES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 53. NORTH AMERICA STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 54. EUROPE STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 55. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 56. LAMEA STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 57. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 58. ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 59. BRAILE: COMPANY SNAPSHOT
TABLE 60. BRAILE: PRODUCT CATEGORIES
TABLE 61. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 62. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 63. CRYOLIFE: COMPANY SNAPSHOT
TABLE 64. CRYOLIFE: OPERATING SEGMENTS
TABLE 65. EDWARDS: COMPANY SNAPSHOT
TABLE 66. JENAVALVE: COMPANY SNAPSHOT
TABLE 67. LIVANOVA: COMPANY SNAPSHOT
TABLE 68. LIVANOVA: OPERATING SEGMENTS
TABLE 69. MTE: COMPANY SNAPSHOT
TABLE 70. MTE: PRODUCT CATEGORIES
TABLE 71. MEDTRONIC: COMPANY SNAPSHOT
TABLE 72. MEDTRONIC: BUSINESS SEGMENTS
TABLE 73. MID: COMPANY SNAPSHOT
TABLE 74. MID: PRODUCT CATEGORIES
LIST OF FIGURES
FIGURE 1. STRUCTURAL HEART DEVICES MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2012-2016 (%)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, 2015
FIGURE 9. CLINICAL TRIALS IN STRUCTURAL HEART DEVICES MARKET
FIGURE 10. CLINICAL TRIALS FOR STRUCTURAL HEART DEVICES (%)
FIGURE 11. COMPLETED CLINICAL TRIALS FOR STRUCTURAL HEART DEVICES MARKET (%)
FIGURE 12. GLOBAL STRUCTURAL HEART REPAIR DEVICES MARKET FOR OCCLUDERS, 2014-2022 ($MILLION)
FIGURE 13. GLOBAL STRUCTURAL HEART REPAIR DEVICES MARKET FOR ANNULOPLASTY RINGS, 2014-2022 ($MILLION)
FIGURE 14. GLOBAL STRUCTURAL HEART REPAIR DEVICES MARKET FOR HEART VALVE BALLOONS, 2014-2022 ($MILLION)
FIGURE 15. GLOBAL STRUCTURAL HEART REPLACEMENT DEVICES MARKET FOR MECHANICAL VALVES, 2014-2022 ($MILLION)
FIGURE 16. GLOBAL STRUCTURAL HEART REPLACEMENT DEVICES MARKET FOR TISSUE VALVES, 2014-2022 ($MILLION)
FIGURE 17. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR NEWBORNS, 2014-2022 ($MILLION)
FIGURE 18. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR INFANTS, 2014-2022 ($MILLION)
FIGURE 19. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR TODDLERS, 2014-2022 ($MILLION)
FIGURE 20. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR PRESCHOOLERS, 2014-2022 ($MILLION)
FIGURE 21. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR SCHOOL-AGED CHILDREN, 2014-2022 ($MILLION)
FIGURE 22. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR ADOLESCENTS, 2014-2022 ($MILLION)
FIGURE 23. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR YOUNG ADULTS, 2014-2022 ($MILLION)
FIGURE 24. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR ADULTHOOD, 2014-2022 ($MILLION)
FIGURE 25. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR MIDDLE-AGED PERSONS, 2014-2022 ($MILLION)
FIGURE 26. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR OLDER PEOPLE/OLD AGE, 2014-2022 ($MILLION)
FIGURE 27. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR VERY OLD, 2014-2022 ($MILLION)
FIGURE 28. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR ATRIAL SEPTAL DEFECT, 2014-2022 ($MILLION)
FIGURE 29. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR PATENT FORAMEN OVALE, 2014-2022 ($MILLION)
FIGURE 30. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR VENTRICULAR SEPTAL DEFECT, 2014-2022 ($MILLION)
FIGURE 31. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR AORTIC VALVE STENOSIS, 2014-2022 ($MILLION)
FIGURE 32. GLOBAL STRUCTURAL HEART DEVICES MARKET FOR OTHER INDICATIONS, 2014-2022 ($MILLION)
FIGURE 33. TOTAL NUMBER OF TAVR CANDIDATES WORLDWIDE
FIGURE 34. U.S. STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 35. CANADA STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 36. MEXICO STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 37. GERMANY STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 38. FRANCE STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 39. UK STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 40. ITALY STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 41. SPAIN STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 42. REST OF EUROPE STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 43. JAPAN STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 44. CHINA STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 45. INDIA STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 46. AUSTRALIA STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 47. MALAYSIA STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 48. REST OF ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 49. BRAZIL STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 50. SOUTH AFRICA STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 51. SOUTH ARABIA STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 52. REST OF LAMEA STRUCTURAL HEART DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 53. ST. JUDE MEDICAL: FINANCIALS, 2013-2015 ($MILLION)
FIGURE 54. ST JUDE MEDICAL: STRATEGY SHARE, 2012-2016 (%)
FIGURE 55. BOSTON: FINANCIALS, 2013-2015 ($MILLION)
FIGURE 56. BOSTON SCIENTIFIC: STRATEGY SHARE, 2011-2016 (%)
FIGURE 57. CRYOLIFE: FINANCIALS, 2013-2015 ($MILLION)
FIGURE 58. CRYOLIFE: STRATEGY SHARE, 2011-2016 (%)
FIGURE 59. EDWARDS: FINANCIALS, 2013-2015 ($MILLION)
FIGURE 60. EDWARDS: STRATEGY SHARE, 2014-2016 (%)
FIGURE 61. JENAVALVE: STRATEGY SHARE, 2011-2013 (%)
FIGURE 62. LIVANOVA: FINANCIALS, 2013-2015 ($MILLION)
FIGURE 63. LIVANOVA: STRATEGY SHARE, 2016 (%)
FIGURE 64. MEDTRONIC: FINANCIALS, 2014-2016 ($MILLION)
FIGURE 65. MEDTRONIC: STRATEGY SHARE, 2015-2016 (%)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
